Physician profile
Heather Cheaney
NPI 1225487143
$4,319.66
in general payments reported to CMS, 2019-2025
42 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Family Health provider received nationally (typical 2025 total: $209).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,144 · 2022: $1,253 · 2023: $993 · 2024: $660 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,461.64 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $226.80 | 2021-2024 | Rexulti |
| Glaxosmithkline, LLC. | $187.70 | 2021-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Novo Nordisk INC | $168.08 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $147.17 | 2022 | |
| Lilly USA, LLC | $143.70 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $136.92 | 2021-2023 | Veozah |
| Janssen Pharmaceuticals, INC | $129.00 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $128.25 | 2021 | |
| Optinose US, INC. | $122.38 | 2025 | |
| Lundbeck LLC | $115.30 | 2022-2024 | Rexulti |
| Abbott Laboratories | $112.40 | 2022-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.96 | 2021-2024 | Tradjenta, Jardiance, Synjardy |
| Grifols USA, LLC | $89.08 | 2021-2023 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $86.21 | 2023-2024 | Auvelity |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Cheaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.